Back to results
US 8,278,435 B2Granted
N-pyrazole A2A receptor agonists
AssigneeGilead Sciences, Inc.
InventorsJeff A. Zablocki, Elfatih O. Elzein, Venkata Palle, Luiz Belardinelli
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a process for the preparation of 2-adenosine N-pyrazole compounds exemplified by the structure shown below that are potent and selective agonists for A2A adenosine receptor, compositions comprising these compounds, and methods for using these compounds to stimulate mammalian coronary vasodilation for imaging the heart.
Claims14
A method for the preparation of (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide:
- comprising heating a compound of formula 10:
- in excess methylamine to provide (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide.
Dependencies are inferred from the claim text.